|
|
|
|
|
|
|
|
|
26.03.26 - 11:36
|
Daiichi Sankyo and Tempus AI collaborate on ADC clinical development (PBR)
|
|
|
Daiichi Sankyo will utilise Tempus' foundation models such as PRISM2, which integrates pathology images and clinical data to generate diagnostic and predictive insights. The partnership will combine Daiichi
The post Daiichi Sankyo and Tempus AI collaborate on ADC clinical development appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
03.03.26 - 08:12
|
Japan Expert Panel OKs Daiichi Sankyo′s MMR Vaccine (Nippon)
|
|
|
Tokyo, March 3 (Jiji Press)--A Japanese panel of experts gave the green light on Monday for the health minister to approve the production and sale of Daiichi Sankyo Co.'s vaccine for measles, mumps and rubella. If approved by the minister, the vaccine, primarily for children, will be the sole MMR vaccine available in Japan. MMR vaccines were introduced as part of routine immunizations in......
|
|
|
20.02.26 - 01:03
|
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D (Business Wire)
|
|
|
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (TSE: 4568) has appointed John Tsai, MD to succeed Ken Takeshita, MD, who is stepping down as Global Head of R&D, effective April 1, 2026.
Dr. Tsai will bring more than 25 years of proven leadership and experience driving innovation to further grow the rich Daiichi Sankyo pipeline, as well as lead the acceleration of new science to bring needed medicines to patients. He will join from venture capital firm Syncona Investment Management, where he was an Executive Partner responsible for starting new biotech companies based on scientific innovation and also driving execution across several biotech companies focused on oncology, cardiovascular and kidney disease therapeutic areas.
Previously, Dr. Tsai was the President and Head of Global Drug Development and Chief Medical Officer of Novartis AG where he led the development of 160 new projects and 500 clinical trials leading to global approvals for 15 new medicines, including new bre...
|
|
|
|
|
01.02.26 - 07:06
|
OTC Sales of Emergency Contraception to Start in Japan Mon. (Nippon)
|
|
|
Tokyo, Feb. 1 (Jiji Press)--Over-the-counter sales of an emergency contraceptive pill, aimed at preventing unwanted pregnancy, are set to start in Japan on Monday. The pill, Norlevo from Daiichi Sankyo Healthcare Co., has a suggested retail price of 7,480 yen per tablet. Taking one pill within 72 hours of sexual intercourse can prevent pregnancy with a probability of about 80 pct. In Jap......
|
|
|
|
|
|
|
|
|
22.01.26 - 07:36
|
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe (Business Wire)
|
|
|
TOKYO & MUNICH--(BUSINESS WIRE)--Daiichi Sankyo (TSE:4568) has appointed Veronika Rozehnal, Ph.D., to succeed Jürgen Müller, Ph.D., as the Head of the Translational Research Center Europe.
Dr. Jürgen Müller will retire after nearly 30 years of research work at Daiichi Sankyo. Under his leadership, the Translational Research Center Europe, previously called the Tissue and Cell Research Center Munich, has grown from three to 40 researchers since it was founded in 1997 and has become an internationally recognized institution that plays a strategic role in the global innovation process of Daiichi Sankyo.
Dr. Veronika Rozehnal joined Daiichi Sankyo in 2009 and has held various positions at the Translational Research Center Europe in addition to spending three years at the Daiichi Sankyo R&D Center in Tokyo. Dr. Rozehnal graduated from Ernst-Moritz-Arndt University of Greifswald, Germany with a Ph.D. degree in Clinical Pharmacology.
“Jürgen Müller has made significant scientific contributions that have ...
|
|
|
|
|
21.01.26 - 08:00
|
Research: Bernstein Lists Top Picks in Asia-Pacific for 1H26 (Table) (AAStocks)
|
|
|
CNOOC (00883.HK)JD.com (JD.US) (09618.HK)SK hynix (000660.KS)Samsung Electronics (005930.KS)Tokyo Electron (8035.JP)Kokusai (6525.JP)Renesas (6723.JP)Power Finance (POWF.IN)Record plc (RECL.IN)Daiichi Sankyo (4568.JP)Eisai Co (4523.JP)Rio Tinto (RIO.AU)Piotech (688072.SH)MediaTek (2454.TW)Tianqi Lithium (002466.SZ) (09696.HK)Doo......
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
